In this presentation, A/Prof Raimondo Bruno (School of Medicine, University of Tasmania), discusses existing knowledge around synthetic cannabinoids and presents findings from the 2018 national Ill
This webinar looks at the use of opioid agonist treatment, primarily methadone and buprenorphine, for the treatment of pharmaceutical opioid dependence.
Presented at the NDARC Annual Symposium, Sydney, 28 August, 2012.
Professor Alison Ritter, director of the Drug Policy Modelling Program at NDARC, co-hosted a webinar on the current policy landscape and future opportunities for campaigning on drug law reform with
This is a copy of the presentation made by Dr Delyse Hutchinson at the 2015 NDARC Annual Research Symposium in Session Two.